粪便菌群中出现甲氧苄啶耐药性。
Emergence of trimethoprim resistance in fecal flora.
作者信息
Huovinen P, Mattila T, Kiminki O, Pulkkinen L, Huovinen S, Koskela M, Sunila R, Toivanen P
出版信息
Antimicrob Agents Chemother. 1985 Aug;28(2):354-6. doi: 10.1128/AAC.28.2.354.
Abstract
The emergence of trimethoprim (TMP) resistance in fecal flora was compared in patients with urinary tract infection treated with TMP or TMP-sulfamethoxazole. No significant differences were found in the occurrence of TMP-resistant fecal aerobic bacteria in the two treatment groups before and after treatment.
摘要
对接受甲氧苄啶（TMP）或甲氧苄啶-磺胺甲恶唑治疗的尿路感染患者粪便菌群中TMP耐药性的出现情况进行了比较。在两个治疗组中，治疗前后粪便需氧菌中TMP耐药菌的发生率没有发现显著差异。
相似文献
1
Emergence of trimethoprim resistance in fecal flora.粪便菌群中出现甲氧苄啶耐药性。
Antimicrob Agents Chemother. 1985 Aug;28(2):354-6. doi: 10.1128/AAC.28.2.354.
2
Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.甲氧苄啶及甲氧苄啶-磺胺甲恶唑对耐药性阴道和粪便菌群形成的影响。
Antimicrob Agents Chemother. 1980 Feb;17(2):263-8. doi: 10.1128/AAC.17.2.263.
3
Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.服用复方磺胺甲恶唑或单独服用甲氧苄啶患者粪便菌群的耐药性。
Antimicrob Agents Chemother. 1981 Jan;19(1):33-8. doi: 10.1128/AAC.19.1.33.
4
Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.甲氧苄啶-磺胺甲恶唑及单独使用甲氧苄啶预防儿童尿路感染
Rev Infect Dis. 1982 Mar-Apr;4(2):461-6. doi: 10.1093/clinids/4.2.461.
5
Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.萘啶酸与甲氧苄啶/磺胺甲恶唑治疗育龄期女性急性尿路感染的疗效与安全性比较
Antimicrob Agents Chemother. 1981 Apr;19(4):598-604. doi: 10.1128/AAC.19.4.598.
6
Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.用甲氧苄啶与磺胺异恶唑治疗单纯性尿路感染，并特别提及抗体包被细菌和粪便菌群。
Antimicrob Agents Chemother. 1981 May;19(5):842-50. doi: 10.1128/AAC.19.5.842.
7
Trimethoprim alone for treatment of urinary tract infection.单独使用甲氧苄啶治疗尿路感染。
Rev Infect Dis. 1982 Mar-Apr;4(2):366-71. doi: 10.1093/clinids/4.2.366.
8
Trimethoprim once daily vs. nitrofurantoin in treatment of acute urinary tract infections in young women, with special reference to periurethral, vaginal, and fecal flora.每日一次服用甲氧苄啶与服用呋喃妥因治疗年轻女性急性尿路感染的比较，特别涉及尿道周围、阴道及粪便菌群
Rev Infect Dis. 1982 Mar-Apr;4(2):378-87. doi: 10.1093/clinids/4.2.378.
9
Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.口服甲氧苄啶或甲氧苄啶-磺胺甲恶唑期间粪便中大肠杆菌出现高水平甲氧苄啶耐药性。
N Engl J Med. 1982 Jan 21;306(3):130-5. doi: 10.1056/NEJM198201213060302.
10
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.诺氟沙星与甲氧苄啶-磺胺甲恶唑治疗女性局部急性症状性尿路感染的对比试验及其对尿道周围和粪便微生物群的抗菌作用
Antimicrob Agents Chemother. 1984 Oct;26(4):481-4. doi: 10.1128/AAC.26.4.481.
引用本文的文献
1
β-Lactam-Resistant Streptococcus pneumoniae Dynamics Following Treatment: A Dose-Response Meta-analysis.β-内酰胺类耐药肺炎链球菌治疗后的动态变化：剂量反应荟萃分析。
Clin Infect Dis. 2022 Nov 30;75(11):1962-1970. doi: 10.1093/cid/ciac293.
2
Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis.抗生素暴露后个体的耐药性衰减：系统评价和荟萃分析。
BMC Med. 2018 Aug 7;16(1):126. doi: 10.1186/s12916-018-1109-4.
3
Screening for antimicrobial resistance in fecal samples by the replica plating method.通过影印接种法对粪便样本中的抗菌素耐药性进行筛查。
J Clin Microbiol. 1995 Dec;33(12):3146-9. doi: 10.1128/jcm.33.12.3146-3149.1995.
4
Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings.有或无银汞合金补牙的人群粪便菌群中需氧革兰氏阴性杆菌的抗微生物及抗汞性
Antimicrob Agents Chemother. 1995 Nov;39(11):2499-502. doi: 10.1128/AAC.39.11.2499.
5
A novel dihydrofolate reductase cassette inserted in an integron borne on a Tn21-like element.一个插入在类Tn21元件携带的整合子中的新型二氢叶酸还原酶盒。
Antimicrob Agents Chemother. 1993 Jun;37(6):1297-304. doi: 10.1128/AAC.37.6.1297.
6
Trimethoprim and sulfonamide resistance.甲氧苄啶和磺胺耐药性。
Antimicrob Agents Chemother. 1995 Feb;39(2):279-89. doi: 10.1128/AAC.39.2.279.
7
Trimethoprim resistance.甲氧苄啶耐药性
Antimicrob Agents Chemother. 1987 Oct;31(10):1451-6. doi: 10.1128/AAC.31.10.1451.
本文引用的文献
1
Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.甲氧苄啶及甲氧苄啶-磺胺甲恶唑对耐药性阴道和粪便菌群形成的影响。
Antimicrob Agents Chemother. 1980 Feb;17(2):263-8. doi: 10.1128/AAC.17.2.263.
2
Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.服用复方磺胺甲恶唑或单独服用甲氧苄啶患者粪便菌群的耐药性。
Antimicrob Agents Chemother. 1981 Jan;19(1):33-8. doi: 10.1128/AAC.19.1.33.
3
Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.口服甲氧苄啶或甲氧苄啶-磺胺甲恶唑期间粪便中大肠杆菌出现高水平甲氧苄啶耐药性。
N Engl J Med. 1982 Jan 21;306(3):130-5. doi: 10.1056/NEJM198201213060302.
4
Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.用甲氧苄啶与磺胺异恶唑治疗单纯性尿路感染，并特别提及抗体包被细菌和粪便菌群。
Antimicrob Agents Chemother. 1981 May;19(5):842-50. doi: 10.1128/AAC.19.5.842.
5
Trimethoprim resistance in hospitals.医院中的甲氧苄啶耐药性。
Br Med J (Clin Res Ed). 1982 Mar 13;284(6318):782-4. doi: 10.1136/bmj.284.6318.782.
6
Laser nephelometric semi-automated system for rapid bacterial susceptibility testing.用于快速细菌药敏试验的激光散射比浊半自动系统。
J Antimicrob Chemother. 1983 Sep;12(3):257-63. doi: 10.1093/jac/12.3.257.
7
Trimethoprim-resistant Escherichia coli in a geriatric hospital.一家老年医院中对甲氧苄啶耐药的大肠杆菌
J Infect. 1984 Mar;8(2):145-8. doi: 10.1016/s0163-4453(84)92530-1.
8
Comparison of trimethoprim alone with trimethoprim sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance.单独使用甲氧苄啶与复方磺胺甲恶唑治疗呼吸道和泌尿系统感染的比较，特别涉及甲氧苄啶耐药性的选择。
Lancet. 1980 Jun 14;1(8181):1270-3. doi: 10.1016/s0140-6736(80)91732-8.
9
R Factors in Escherichia coli in faeces after oral chemotherapy in general practice.
Lancet. 1971 Feb 13;1(7694):312-5. doi: 10.1016/s0140-6736(71)91042-7.
10
Trimethoprim resistance in Gram negative urinary pathogens.革兰氏阴性泌尿系统病原体对甲氧苄啶的耐药性。
Br Med J (Clin Res Ed). 1985 Jan 12;290(6462):156. doi: 10.1136/bmj.290.6462.156.
Zotero 插件